Tumor website：www.tumorsci.org E-mail Alert
After third generation EGFR-TKI resistance, where is the path of advanced NSCLC patients with EGFR mutations
PENG Ling, DONG Xiaorong
Tumor . 2024, (06): 566 -573 .  DOI: 10.3781/j.issn.1000-7431.2024.2404-0180

Copyright © Tumor, All Rights Reserved.
E-mail: tumor@tumorsci.org
Powered by Beijing Magtech Co., Ltd.